Jenscare Scientific (HKG:9877) reported 169.6 million yuan in attributable loss for the first half of 2025, widening from a loss of 102.3 million yuan a year earlier, according to a Hong Kong bourse filing Wednesday.
Loss per share was 0.41 yuan, compared with 0.25 yuan in the prior year.
The medical device company generated 13.4 million yuan in revenue during the period. It reported no revenue for the corresponding period last year.